Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.135 USD | +1.34% | -1.74% | -36.52% |
May. 10 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
May. 10 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.52% | 82.11M | |
+47.51% | 57.87B | |
+41.08% | 40.25B | |
-7.11% | 39.94B | |
-5.96% | 28.54B | |
+11.96% | 26.4B | |
-20.40% | 19.33B | |
+30.11% | 12.4B | |
-0.94% | 12.23B | |
+24.23% | 12.2B |
- Stock Market
- Equities
- PLX Stock
- News Protalix BioTherapeutics, Inc.
- Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q1 Revenue $3.7M, vs. Street Est of $9.2M